Skip to content

DAILIES TOTAL1® - Comparative Assessment of Tear Film Evaporation

Pilot Study on the Effect of Daily Disposable Silicone Hydrogel Contact Lenses on Tear Film Lipids

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02517567
Enrollment
37
Registered
2015-08-07
Start date
2015-09-21
Completion date
2016-04-22
Last updated
2018-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Error

Brief summary

The purpose of this study is to evaluate the tear film evaporation of symptomatic soft contact lens wearers in the absence of contact lens wear and after at least 8 hours of contact lens wear.

Detailed description

This study consists of 5 visits (1 screening, 4 assessment) with a maximum of 6 days between assessment visits and at least 24 hours of no lens wear the day prior to the visit. Each subject will be randomized to a crossover sequence of 4 periods. Different study lenses will be worn during 3 of the periods, for at least 8 hours each, and the remaining period will have no lens wear.

Interventions

Daily disposable, silicone hydrogel contact lenses used according to manufacturer's instructions

Daily disposable, silicone hydrogel contact lenses used according to manufacturer's instructions

Daily disposable, silicone hydrogel contact lenses used according to manufacturer's instructions

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Sign an informed consent document; * Adapted, current soft contact lens wearer; * Symptoms of contact lens discomfort as defined by the Symptomatology (Eligibility) Questionnaire; * Can be successfully fitted with study lenses; * Willing to wear lenses for a minimum of 8 hours prior to each study visit; * Willing to discontinue artificial tears and rewetting drops usage on the days of study visits; * Other protocol-specified inclusion criteria may apply.

Exclusion criteria

* Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear; * Use of systemic or ocular medications for which contact lens wear could be contraindicated as determined by the investigator; * Monocular (only 1 eye with functional vision) or fit with only one lens; * History of herpetic keratitis, ocular surgery, or irregular cornea; * Known pregnancy and lactation; * Other protocol-specified

Design outcomes

Primary

MeasureTime frameDescription
Tear Film Evaporation RateDay 1, Hour 8, each productTear film evaporation rate (amount of tears (grams or g) that evaporates over a surface area (m2) per hour (h)) assessment was performed using the VapoMeter as a non-invasive measurement of tear film evaporation over 10 seconds. Measurements were taken on both the right and left eyes after 8 hours of lens wear or no lens wear, as applicable. A higher evaporation rate can be a contributing factor to eye irritation and lens intolerance.

Participant flow

Recruitment details

Subjects were recruited from 1 study center located in Australia.

Pre-assignment details

Of the 37 enrolled, 7 subjects were exited as screen failures prior to randomization and 1 subject discontinued after randomization prior to exposure to the investigational product. This reporting group includes all randomized and exposed subjects (29).

Participants by arm

ArmCount
Overall
Delefilcon A, narafilcon A, and somofilcon A contact lenses worn bilaterally (in both eyes) and a period of no lens wear in a randomized crossover fashion
29
Total29

Baseline characteristics

CharacteristicOverall
Age, Continuous23.7 years
STANDARD_DEVIATION 5.36
Sex: Female, Male
Female
21 Participants
Sex: Female, Male
Male
8 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
deaths
Total, all-cause mortality
0 / 370 / 290 / 280 / 290 / 29
other
Total, other adverse events
0 / 370 / 290 / 280 / 290 / 29
serious
Total, serious adverse events
0 / 370 / 290 / 280 / 290 / 29

Outcome results

Primary

Tear Film Evaporation Rate

Tear film evaporation rate (amount of tears (grams or g) that evaporates over a surface area (m2) per hour (h)) assessment was performed using the VapoMeter as a non-invasive measurement of tear film evaporation over 10 seconds. Measurements were taken on both the right and left eyes after 8 hours of lens wear or no lens wear, as applicable. A higher evaporation rate can be a contributing factor to eye irritation and lens intolerance.

Time frame: Day 1, Hour 8, each product

Population: This analysis population includes all randomized subjects (Intent-to-Treat). To address the primary objective of comparing Lens vs. No Lens, results from all 3 study lenses are combined. Therefore, subjects (eyes) are counted multiple times in Lens group due to crossover design and number of eyes with non-missing response is reported.

ArmMeasureValue (MEAN)Dispersion
LensTear Film Evaporation Rate120.88 gm^-2 hStandard Deviation 45.563
No LensTear Film Evaporation Rate105.63 gm^-2 hStandard Deviation 53.361

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026